Trade Shows

Trade Resources Search Results

Type

Location

Industry

View More

2 results for "

Cancer Pain Therapy

"

Kyowa Hakko Kirin Has Sought Japanese Approval for KW-2246 as Cancer Pain Medication
Dec 4, 2012
Kyowa Hakko Kirin, Orexo's partner, has filed a new drug application (NDA) seeking Japanese approval for KW-2246 as cancer pain medication. The sublingual formulation of fentanyl earlier gained approval in US, EU and Canada as cancer ...

Tags: new drug application, cancer pain medication, pharmaceutical product
BDSI Has Announced The Introduction of Breakyl in The EU by Meda
Nov 28, 2012
BioDelivery Sciences International (BDSI) has announced the introduction of Breakyl (fentanyl buccal film) in the European Union (EU) by Meda, its commercial partner for the product in the region. The launch triggered a $2.5m final EU ...

Tags: Cancer Pain Therapy, Breakyl, pain management

Related Products